comparemela.com
Home
Live Updates
Scancell doses first patient in melanoma-focused trials : co
Scancell doses first patient in melanoma-focused trials : co
Scancell doses first patient in melanoma-focused trials
Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic.
The Oxford, England-based developer of immunotherapies for...
Related Keywords
London ,
City Of ,
United Kingdom ,
Elijah Dale ,
Alliance News Ltd ,
Alliance News ,
Scancell Holdings ,
All Rights ,